Poland· PL-100419948
Kuvan
A sapropterin product containing sapropterinum, registered in Poland by BioMarin International Ltd.. The same ATC class is registered in 19 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Sapropterin is registered in 19 of 19 countries.
Countries holding a registration under ATC A16AX07 (sapropterin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 11 of them publish a price we can compare per daily dose
Sapropterin · ATC A16AX07
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of sapropterin costs, country by country.
Normalised to the WHO defined daily dose (0.7 g), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Sapropterin · price per daily dose (0.7 g)
USD · FX 28 Sept 2026
- CH Switzerland$159.61
- IT Italy$156.69
The record
At a glance
URPL (Poland)- Active substance
- Sapropterinum
- Manufacturer
- BioMarin International Ltd.
- Country
- Poland (PL)
- ATC code
- A16AX07
- ATC class
- Sapropterin
- Defined daily dose
- 0.7 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991408220
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
29 interactions on record for sapropterin.
Graded by severity as the source publishes them — 29 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Sapropterin · interactions on record
29 records
- 29 moderate
Most severe, free to view
- Glyceryl trinitrateC01DA02moderate
- Isosorbide dinitrateC01DA08moderate
- Isosorbide mononitrateC01DA14moderate
- NesiritideC01DX19moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Sapropterin in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesJAVYGTORDr. Reddys Laboratories Inc
- CzechiaKUVANBioMarin International Limited, Dublin
- IrelandKuvan 100 mg powder for oral solutionBiomarin International Limited
- FinlandKuvanBiomarin International Limited
- BelgiumKuvan 100 mgBioMarin International
- IcelandKuvanBioMarin International Limited
- SwedenKuvan 100 mg Pulver till oral lösningBioMarin International Limited
- CanadaREDDY-SAPROPTERINDR REDDY'S LABORATORIES LTD
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Bulgaria · Сапроптерин Тева
- Czechia · Sapropterin Piam Farmaceutici
- Germany · Arpetran, Sapropterin Al
- Denmark · Arpetran, Sapropterin Sandoz
- Spain · Sapropterina Aurovitas, Sapropterina Elc
- France · Sapropterine Arrow, Sapropterine Teva
- United Kingdom (Northern Ireland) · Sapropterin Dihydrochloride, Sapropterin Dihydrochloride Amarox
- Iceland · Kuvan, Sapropterin Dipharma
- Italy · Arpetran, Sapropterina Aurobindo
- Liechtenstein · Kuvan, Sapropterin Dipharma
- Malta · Sapropterina Generis
- Netherlands · Arpetran, Sapropterin Aurobindo
- Norway · Kuvan, Sapropterin Dipharma
- Portugal · Arpetran, Sapropterina Generis
- Sweden · Sapropterin Stada, Sapropterin Teva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d5034f6c-1c36-446c-9c8a-0d736cdc4c29 GET /v1/drugs/d5034f6c-1c36-446c-9c8a-0d736cdc4c29?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek do sporządzania roztworu doustnego",
"source": "urpl",
"strength": "100 mg",
"packaging": "05909991408220 ¦ Rpz ¦ EU/1/08/481/004 ¦ 132570\n30 sasz. 100 mg",
"substance": "Sapropterini dihydrochloridum 100 mg",
"common_name": "Sapropterinum",
"pl_product_id": "100419948",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about sapropterin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.